Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 18 of 100
Commentary
Our changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By
Martine Ferland
and
Judy Monroe
November 15, 2023
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By
Ryan Hogg
November 6, 2023
Mind
Just 1 sleepless night could actually lead to a dopamine boost—and reverse depression for several days
By
Erin Prater
November 3, 2023
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By
Prarthana Prakash
November 3, 2023
Newsletters
Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump
By
Sheryl Estrada
November 3, 2023
Newsletters
CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business
By
Jessica Mathews
October 31, 2023
Health
Dozens of eyedrops sold over-the-counter can infect your eyes and make you go blind, FDA says
By
The Associated Press
October 30, 2023
Health
U.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By
Christiaan Hetzner
October 28, 2023
Commentary
Climate change is our greatest health crisis. The same investments can often address both threats
By
Vanessa Kerry
and
Paul Hudson
October 19, 2023
Health
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By
Angel Adegbesan
and
Bloomberg
October 13, 2023
Health
Horseshoe crab blood is vital to modern medicine. A new lab-made alternative could save the species
By
Kristoffer Whitney
,
Jolie Crunelle
and
The Conversation
October 13, 2023
Health
CVS CEO says pharmacist burnout led to a walkout: ‘We are at the same level of demand as we were in 2021’ for COVID shots
By
Erin Prater
October 10, 2023
Finance
Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By
Prarthana Prakash
October 10, 2023
Health
‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By
Tom Murphy
and
The Associated Press
October 7, 2023
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Chloe Taylor
October 5, 2023
Most Popular
Personal Finance
The national debt isn't $39 trillion. One economist says it's actually $100 trillion
By
Nick Lichtenberg
Success
When Jamie Dimon was fired from Citigroup, his daughters asked: 'Will we be homeless? Can I still go to college? Can I...
By
Eleanor Pringle
North America
The U.S. Mint dropped the olive branch from the dime. What does that mean for the country?
By
Catherina Gioino